{"page_content": "OPERATING RESPONSIBLY ENVIRONMENT REPORTING WORKPLACE PATIENTS COMMUNITY COMMITMENT\nAmgen 2016 Responsibility Highlights Report    21REPORTING\nGlobal Reporting Initiative Index (continued)\nIdentified Material Aspects and Boundaries\nNumber Disclosure Reported Response\nG4-17 Entities covered by the report Amgen facilities within the scope of this report are as follows:\nUnited States: Thousand Oaks, California; Cambridge, Massachusetts; Woburn, Massachusetts; \nWest Greenwich, Rhode Island; Louisville, Kentucky; South San Francisco, California; Longmont, \nColorado; Juncos, Puerto Rico; Bothell, Washington; Field Sales U.S. Fleet\nCanada:  Burnaby, British Columbia\nEurope:  Breda, Netherlands; Uxbridge, Abingdon and Cambridge, United Kingdom; \nDun Laoghaire, Ireland\nBrazil: Sao Paulo\nTurkey:  Yenibosna and Sekerpinar\nSingapore:  Tuas\nG4-18 Process for defining report content and determining boundaries for aspects www.amgen.com (Responsibility/2016 Responsibility Highlights Report)\nwww.amgen.com (Responsibility/Environment/Commitment)\nG4-19 List all material aspects www.amgen.com (Responsibility/Environment/Commitment)\nG4-22 Effects of any restatements from information provided in previous reports None\nG4-23 Significant changes from previous reports in scope or aspect boundaries Data from our facility in Singapore is now included in the 2016 report.\nStakeholder Engagement\nNumber Disclosure Reported Response\nG4-24 Stakeholder groups engaged by the organization www.amgen.com (Responsibility/2016 Responsibility Highlights Report)\nwww.amgen.com (Responsibility/Environment/Commitment)\nReported PartialREPORTING", "metadata": {"source": "NASDAQ_AMGN_2016.pdf", "page": 20, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}